Vital Images has filed a 510(k) application with the Food andDrug Administration for a new, more advanced version of its 3-Dimage processing software, according to the company's parent,Bio-Vascular of St. Paul, MN. The new version builds on VitalImages'
Vital Images has filed a 510(k) application with the Food and
Drug Administration for a new, more advanced version of its 3-D
image processing software, according to the company's parent,
Bio-Vascular of St. Paul, MN. The new version builds on Vital
Images' existing 3-D product, VoxelView 2.5, but is faster and
easier to use. The company plans to display the new version at
this year's Radiological Society of North America meeting. Vital
Images has an agreement with ATL of Bothell, WA, to develop 3-D
ultrasound image processing software (SCAN 8/28/96).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.